Just lately the outcomes of the Lenire® TENT-A1 scientific trial for the remedy of tinnitus have been revealed in Science Translational Drugs. Watch the recording of this interactive webinar protecting the breakthrough analysis.
Whether or not you are a healthcare skilled captivated with treating tinnitus or a affected person looking for to grasp how bimodal neuromodulation works – this session is for you.
Dr. John Coverstone, Scientific Audiologist at Sentient Healthcare joins Dr. Ross O’Neill, CEO at Neuromod Gadgets, Professor Hubert Lim, Chief Scientific Officer at Neuromod Gadgets, and Mr. Brendan Conlon Chief Medical Officer at Neuromod Gadgets and Principal Investigator of the TENT-A1 trial to debate:
– How Bimodal Neuromodulation was proven to assuage tinnitus signs within the majority of contributors;
– How the TENT-A1 trial was designed and run;
– What the TENT-A1’s outcomes imply for tinnitus sufferers and the way forward for Lenire®.